Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes. - Cai YR; Dong YJ; Wu HB; Yu DP; Zhou LJ; Su D; Zhang L; Chen XJ (Oncology letters, 2016)